Arrowhead Pharmaceuticals, Inc.

UBS Group AG ARWR

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/29/2026

Shares

987,287

Value ($000)

65,546

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/29/2026	65,546	0.0%	987,287	12/31/2025
2025 Q3	11/13/2025	31,668	0.0%	918,183	9/30/2025
2025 Q2	8/14/2025	25,289	0.0%	1,600,596	6/30/2025
2025 Q1	5/13/2025	20,722	0.0%	1,626,563	3/31/2025
2024 Q4	2/14/2025	24,540	0.0%	1,305,329	12/31/2024
2024 Q3	11/14/2024	8,552	0.0%	441,511	9/30/2024
2024 Q2	8/14/2024	9,052	0.0%	348,304	6/30/2024
2024 Q1	5/13/2024	12,896	0.0%	450,921	3/31/2024
2023 Q4	2/9/2024	15,563	0.0%	508,586	12/31/2023
2023 Q3	11/9/2023	9,931	0.0%	369,602	9/30/2023
2023 Q2	8/11/2023	11,802	0.0%	330,970	6/30/2023
2023 Q1	5/12/2023	7,603	0.0%	299,342	3/31/2023
2022 Q4	2/8/2023	12,481	0.0%	307,710	12/31/2022
2022 Q3	11/10/2022	3,422	0.0%	103,546	9/30/2022
2022 Q2	8/10/2022	3,212	0.0%	91,217	6/30/2022
2022 Q1	5/16/2022	7,328	0.0%	159,326	3/31/2022
2021 Q4	2/14/2022	10,278	0.0%	155,016	12/31/2021
2021 Q3	11/15/2021	8,116	0.0%	130,000	9/30/2021
2021 Q2	8/13/2021	5,981	0.0%	72,213	6/30/2021
2021 Q1	5/12/2021	4,771	0.0%	71,941	3/31/2021
2020 Q4	2/11/2021	887	0.0%	11,555	12/31/2020
2020 Q3	11/12/2020	1,427	0.0%	33,138	9/30/2020
2020 Q2	7/31/2020	337	0.0%	7,804	6/30/2020
2020 Q1	5/1/2020	347	0.0%	12,053	3/31/2020
2019 Q4	2/14/2020	13,204	0.0%	208,175	12/31/2019